Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
Omega-3 Pharmaceutical Approved in Norway
January 14, 2002
1 Min Read
Omega-3 Pharmaceutical Approved in Norway
LYSAKER, Norway--OMACOR, a high-potency formulation ofomega-3s (EPA and DHA), was approved in Norway for the treatment of post-infarctpatients. It shows similar therapeutic effects to other cardiovascular therapiessuch as anti-hypertensives, statins and anti-platelets. The formulation has alsobeen approved in the United Kingdom, Germany, France, Austria and Greece. OMACORwas developed from research by Pronova Biocare (www.pronova.com).
You May Also Like